Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

FineTech changes hands again

February 6, 2006 | A version of this story appeared in Volume 84, Issue 6

Par Pharmaceutical has sold its pharmaceutical fine chemicals business, FineTech Laboratories, to FineTech's CEO, Arie L. Gutman. Par says in a government filing that FineTech was not profitable and that the sale will save it $4 million a year. Par bought FineTech from International Specialty Products in 2002, less than a year after ISP acquired the Haifa, Israel-based operation. FineTech will continue to supply Par with certain active pharmaceutical ingredients.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.